Kawagashira Yuichi, Watanabe Hirohisa, Oki Yumiko, Iijima Masahiro, Koike Haruki, Hattori Naoki, Katsuno Masahisa, Tanaka Fumiaki, Sobue Gen
Nagoya University Graduate School of Medicine, Nagoya, Nagoya, 466-8550, Japan.
BMJ Case Rep. 2009;2009. doi: 10.1136/bcr.08.2008.0656. Epub 2009 Jan 23.
A 57-year-old man with type 2 diabetes mellitus for 10 years showed progressive loss of muscle strength in both legs, pain and muscle atrophy in the femoral region and significant weight loss. On admission, he could not stand alone and used a wheelchair. He also complained of severe pain in the lower extremities. He was diagnosed with proximal diabetic neuropathy (PDN) by characteristic clinical and electrophysiological features. Intravenous immunoglobulin therapy (IVIg 0.4 g/kg×5 days) markedly reduced the severe pain and muscle weakness in the legs. Eventually, pain assessed by the Visual Analogue Scale was relieved by 80% and muscle strength was also well recovered, thereby enabling the patient to walk with a cane. The present case suggests that IVIg therapy may be effective for the relief of pain in PDN.
一名患有2型糖尿病10年的57岁男性,出现双下肢肌肉力量进行性丧失、股部疼痛和肌肉萎缩以及显著体重减轻。入院时,他无法独自站立,需使用轮椅。他还诉说下肢剧痛。根据典型的临床和电生理特征,他被诊断为近端糖尿病性神经病变(PDN)。静脉注射免疫球蛋白治疗(IVIg 0.4 g/kg×5天)显著减轻了腿部严重疼痛和肌肉无力。最终,视觉模拟评分法评估的疼痛缓解了80%,肌肉力量也得到良好恢复,患者从而能够拄着拐杖行走。本病例提示IVIg治疗可能对缓解PDN疼痛有效。